Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy.
Science., Nov;334(6059):1129-33 (2011)
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
Eur. J. Cancer., Jun;47(9):1373-9 (2011)
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.
Blood., Mar;97(5):1211-8 (2001)
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.
J. Exp. Med., Feb;209(2):259-73 (2012)
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols.
Br. J. Haematol., Feb;152(4):452-9 (2011)
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
Pediatr Blood Cancer., Sep;57(3):492-8 (2011)
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Blood., Oct;118(15):4169-73 (2011)
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).
Leukemia., Feb;24(2):320-34 (2010)
Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.
Blood., Apr;115(14):2845-51 (2010)
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.
J. Clin. Oncol., Aug;28(24):3816-23 (2010)
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
Blood., Feb;115(7):1351-3 (2010)
Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.
Blood., Sep;106(5):1749-54 (2005)
Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.
Cancer Res., Nov;65(21):10050-8 (2005)
Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival.
Exp. Hematol., May;34(5):610-21 (2006)
Myths and lessons from the adult/pediatric interface in acute lymphoblastic leukemia.
Hematology Am Soc Hematol Educ Program., 128-32 (2006)
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
J. Clin. Oncol., Mar;25(7):813-9 (2007)
Post-irradiation meningioma with sarcoidosis.
J. Neurooncol., May;82(3):271-2 (2007)
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.
Blood., Sep;110(5):1607-11 (2007)
Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
J. Clin. Oncol., Nov;25(31):4914-21 (2007)
BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.
Blood., Feb;111(4):2300-9 (2008)